drugset / Trial / NCT06621017
Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to assess the efficacy of ROSE-010 on food intake in female subjects with overweight and obesity. The secondary objectives of this study are the following: * To assess the efficacy of ROSE-010 on hunger; * To assess the efficacy of ROSE-010 on satiety; * To assess the efficacy of ROSE-010 on prospective consumption; * To assess the efficacy of ROSE-010 on desire to eat; * To assess the efficacy of ROSE-010 on palatability; * To characterize the pharmacokinetics (PK) of ROSE-010 following subcutaneous (SC) administration on Day 1 and Day 7; and * To evaluate safety and tolerability of SC administrations of ROSE-010 to overweight and obese subjects.
Timeline
- Start
- 2024-09-26
- Primary completion
- 2025-02-27
- Completion
- 2025-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ROSE-010 | Peptide | 99 ug | Subcutaneous |
| Subject | ROSE-010 | Peptide | 150 ug | Subcutaneous |